Altimmune
NASDAQ:ALTAltimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.
Brookdale Senior Living
NYSE:BKDBrookdale Senior Living Inc. owns, manages, and operates senior living communities in the United States. It operates in three segments: Independent Living, Assisted Living and Memory Care, and Continuing Care Retirement Communities (CCRCs). The Independent Living segment owns or leases communities comprising independent and assisted living units in a single community that are primarily designed for middle to upper income seniors. The Assisted Living and Memory Care segment owns or leases communities consisting of freestanding, multi-story communities and freestanding, single-story communities, which offer housing and 24-hour assistance with activities of daily living for the Company's residents. This segment also operates memory care communities for residents with Alzheimer's and other dementias. The CCRCs segment owns or leases communities that provides various living arrangements, such as independent and assisted living, memory care, and skilled nursing; and services to accommodate various levels of physical ability and healthcare needs. It also manages communities on behalf of others. Brookdale Senior Living Inc. was incorporated in 2005 and is headquartered in Brentwood, Tennessee.
First Trust NYSE Arca Biotechnology Index Fund
NYSEARCA:FBTThe First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.
iLOOKABOUT Corp. (ILA.V)
CVE:ILAiLOOKABOUT Corp., together with its subsidiaries, provides software and data licenses and technology managed services to the real estate industry in Canada and the United States. The company offers GeoViewPort, a web-based platform that enables assessment professionals to simultaneously generate customized portals to view multiple elements related to a property, including street level imagery, aerial imagery, advanced mapping tools, property valuation details, comparable property analysis, and structural characteristics. It also provides FusionOMSm, a web-based platform that enables real property valuation solutions to enterprises through US nationwide repository of public record and multiple listing service data; and Real Property Tax Analytics, a web-based platform that analyzes property assessments. In addition, the company offers data commercialization products and services through the delivery of reports and individual data requests to users through e-commerce transactions or by account, as well as customized reports through an assisted fulfillment process. Further, it provides valuation management and property tax solutions, which include assessment base management, analytics reports, tax policy planning and support, and appeals management. It primarily serves property lending and property tax sectors. iLOOKABOUT Corp. was founded in 2000 and is based in London, Canada.